DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sumatriptan (Sumatriptan) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sumatriptan life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Sumatriptan side effects in 68 year old female

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient: 68 year old female, weighing 70.3 kg (154.7 pounds)

Reactions: Product Substitution Issue, Migraine, Drug Ineffective

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Sumatriptan

Topiramate



Possible Sumatriptan side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-14

Patient: male

Reactions: Cytogenetic Abnormality, Dysmorphism, Maternal Drugs Affecting Foetus, Glaucoma, Pneumonia Aspiration, Micrognathia, Pierre Robin Syndrome, Caesarean Section, Cleft Palate, Developmental Delay, Respiratory Disorder Neonatal, Laryngomalacia, Gastrooesophageal Reflux Disease, Myopia, Ear Infection, Torticollis, Deafness Congenital, Respiratory Distress, Hyperbilirubinaemia Neonatal, Craniosynostosis, Bronchial Hyperreactivity, Respiratory Tract Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Olopatadine Hydrochloride
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Nitrofurantoin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication

Cetirizine
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Azithromycin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Topiramate
    Dosage: 50 mg (25 mg, 2 in 1 d), transplacental
    Indication: Migraine
    Start date: 2010-03-15
    End date: 2010-04-15

Amoxicillin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Ibuprofen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Hydrocodone Bitartrate and Acetaminophen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Sumatriptan
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Fluticasone Propionate
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Cyclobenzaprine
    Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
    Indication: Sciatic Nerve Injury

Naproxen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Prenatal Vitamins (Prenatal Viotamins / 01549301 / )
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication



Possible Sumatriptan side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-04

Patient: male

Reactions: Hyperbilirubinaemia, Maternal Drugs Affecting Foetus, Cytogenetic Abnormality, Glaucoma, Pierre Robin Syndrome, Deafness, Micrognathia, Body Dysmorphic Disorder, Cleft Palate, Caesarean Section, Developmental Delay, Cough, Dyspnoea, Chest Discomfort, Myopia, Craniosynostosis, Bronchial Hyperreactivity

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclobenzaprine
    Dosage: 30 mg (10 mg, 3 in 1 d), transplacental
    Indication: Sciatic Nerve Injury

Amoxicillin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Topiramate
    Dosage: 50;100;1w mg (25 mg, 2 in 1 d), transplacental
    Indication: Migraine

Naproxen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Sumatriptan
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Nitrofurantoin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication

Hydrocodone Bitartrate and Acetaminophen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Prenatal Vitamins (Prenatal Vitamins (01549301)
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication

Fluticasone Propionate
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Azithromycin
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Ibuprofen
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Cetirizine
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Codeine Phosphate, Guaifenesin (Cheracol / 00693301 / )
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25

Olopatadine Hydrochloride
    Dosage: transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-25



Possible Sumatriptan side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-01-23

Patient: 61 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Peripheral Coldness, Antipsychotic Drug Level Increased, Rhabdomyolysis, Contusion, Tachycardia, Mental Status Changes, Pyrexia, Serotonin Syndrome, Muscle Rigidity, Fall, Haemodynamic Instability, Malaise, Aspiration, Cyanosis, Abdominal Distension, Tachypnoea, Electrolyte Imbalance, Neuroleptic Malignant Syndrome, Hypotension, General Physical Health Deterioration, Livedo Reticularis, Antidepressant Drug Level Increased, Apallic Syndrome, Anxiety, Renal Failure, Respiratory Failure, Breath Sounds Abnormal, Depressed Level of Consciousness, Septic Shock, Leukocytosis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Fluconazole
    Dosage: 150 mg;

Trimethoprim
    Dosage: 160 mg; qd

Haloperidol Lactate
    Dosage: 20 mg; hs

Mometasone Furoate
    Dosage: 2 sprays; bid; inh

Alendronate Sodium
    Dosage: 70 mg; qw

Celecoxib
    Dosage: 200 mg; bid

Furosemide
    Dosage: 40 mg; qd

Cyclobenzaprine
    Dosage: 10 mg; prn

Prednisone TAB
    Dosage: 7.5 mg; qd

Hydroxyzine
    Dosage: 25 mg; bid

Loperamide
    Dosage: 2 mg; prn

Hydroxychloroquine Sulfate
    Dosage: 200 mg; bid

Lorazepam
    Dosage: 2 mg; hs;

Omeprazole
    Dosage: 20 mg; bid

Risperidone
    Dosage: 2 mg; qam

Estrogens Conjugated
    Dosage: 1.3 mg; qd

Desipramine HCL
    Dosage: 25 mg; bid

Quetiapine Fumarate
    Dosage: 1800 mgl qd
    Start date: 2009-09-01
    End date: 2009-09-01

Trazodone HCL
    Dosage: 200 mg; qhs

Venlafaxine
    Dosage: 75 mg; bid

Budesonide
    Dosage: 200 mcg; qd; inh

Atorvastatin Calcium
    Dosage: 10 mg; qd

Levothyroxine Sodium
    Dosage: 50 mcg; qd

Sumatriptan
    Dosage: 50 mg; prn

Sulfamethoxazole
    Dosage: 800 mg; qd

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017